George Ioannou

Professor

VA Puget Sound Health Care System

Medicine

Email: georgei@medicine.washington.edu

Research Interest: Pathophysiology and Treatment of Type 2 Diabetes

DRC Publications

Moon, AM; Dominitz, JA; Ioannou, GN; Lowy, E; Beste, L ; Use of Antibiotics Among Patients With Cirrhosis and Upper Gastrointestinal Bleeding Is Associated With Reduced Mortality Clin Gastroenterol Hepatol 2016

Yu, L; Morishima, C; Ioannou, GN ; Sex difference in liver-related mortality and transplantation associated with dietary cholesterol in chronic hepatitis C virus infection Br J Nutr 115 2: 193-201; 2016

Ioannou, GN ; The Role of Cholesterol in the Pathogenesis of NASH Trends Endocrinol Metab 27 2: 84-95; 2016

Berry, K; Ioannou, GN ; Reply Gastroenterology 150 2: 535-7; 2016

Ioannou, GN; Beste, LA; Chang, MF; Green, PK; Lowey, E; Tsui, JI; Su, F; Berry, K ; Effectiveness of Sofosbuvir, Ledipasvir/Sofosbuvir, or Paritaprevir/Ritonavir/Ombitasvir and Dasabuvir Regimens for Treatment of Patients With Hepatitis C in the Veterans Affairs National Health Care System Gastroenterology 2016

Lerrigo, R; Beste, LA; Leipertz, SL; Green, PK; Lok, AS; Kogut, MJ; Ioannou, GN ; Characteristics and outcomes of transjugular intrahepatic portosystemic shunt recipients in the VA Healthcare System Eur J Gastroenterol Hepatol 28 6: 667-75; 2016

Su, F; Yu, L; Berry, K; Liou, IW; Landis, CS; Rayhill, SC; Reyes, JD; Ioannou, GN ; Aging of Liver Transplant Registrants and Recipients: Trends and Impact on Waitlist Outcomes, Post-Transplantation Outcomes, and Transplant-Related Survival Benefit Gastroenterology 150 2: 441-53 e6; quiz e16; 2016

Yarnykh, VL; Tartaglione, EV; Ioannou, GN ; Fast macromolecular proton fraction mapping of the human liver in vivo for quantitative assessment of hepatic fibrosis NMR Biomed 28 12: 1716-25; 2015 PMC4715674

Ioannou, GN; Van Rooyen, DM; Savard, C; Haigh, WG; Yeh, MM; Teoh, NC; Farrell, GC ; Cholesterol-lowering drugs cause dissolution of cholesterol crystals and disperse Kupffer cell crown-like structures during resolution of NASH J Lipid Res 56 2: 277-85; 2015 PMC4306682

Ioannou, GN; Bryson, CL; Weiss, NS; Boyko, EJ ; Associations between lipodystrophy or antiretroviral medications and cirrhosis in patients with HIV infection or HIV/HCV coinfection Eur J Gastroenterol Hepatol 27 5: 577-84; 2015

Runchey, SS; Boyko, EJ; Ioannou, GN; Utzschneider, KM ; Relationship between serum circulating insulin-like growth factor-1 and liver fat in the United States J Gastroenterol Hepatol 29 3: 589-96; 2014 PMC3982202

Savard, C; Tartaglione, EV; Kuver, R; Haigh, WG; Farrell, GC; Subramanian, S; Chait, A; Yeh, MM; Quinn, LS; ... Ioannou, GN Synergistic interaction of dietary cholesterol and dietary fat in inducing experimental steatohepatitis Hepatology 57 1: 81-92; 2013

Smits, MM; Ioannou, GN; Boyko, EJ; Utzschneider, KM ; Non-alcoholic fatty liver disease as an independent manifestation of the metabolic syndrome: results of a US national survey in three ethnic groups J Gastroenterol Hepatol 28 4: 664-70; 2013

Ioannou, GN; Haigh, WG; Thorning, D; Savard, C ; Hepatic cholesterol crystals and crown-like structures distinguish NASH from simple steatosis J Lipid Res 54 5: 1326-34; 2013 PMC3622327

Ioannou, GN; Boyko, EJ ; Effects of menopause and hormone replacement therapy on the associations of hyperuricemia with mortality Atherosclerosis 226 1: 220-7; 2013 PMC4240945

Afzali, A; Berry, K; Ioannou, GN ; Excellent posttransplant survival for patients with nonalcoholic steatohepatitis in the United States Liver Transpl 18 1: 29-37; 2012

Ioannou, GN ; Beyond obesity: is cholesterol-induced liver injury the cause of non-alcoholic steatohepatitis? J Gastroenterol Hepatol 27 9: 1412-4; 2012